Immunology is for everyone

This “Focus on Immunology” issue brings Cell’s 50th anniversary celebrations straight to your lymph nodes! Special Leading Edge articles highlight the exciting past, present, and future of the increasingly interdisciplinary field of immunology.

Atoms

Reining in—October 2023 The hazel door swung ajar onto the penumbrally-lit corridor, the guttural scream of the hinges piercing the silence. The line of mute, quietly agitated applicants for the post uncomfortably positioned on the hard, lime green plastic chairs,

Fantoms

Diagnosis and management of congenital diaphragmatic hernia Editor’s choice for this issue is the updated guideline from the Canadian Congenital Diaphragmatic Hernia Collaborative. This is a very comprehensive document with a rigorous methodology that updates the previous version published in

Lighting the torch: intratumoural T cell-to-stroma enrichment score as a predictor of immunotherapy response in urothelial carcinoma

Nature Reviews Clinical Oncology, Published online: 15 April 2024; doi:10.1038/s41571-024-00890-2 T cell infiltration in the tumour microenvironment (TME) is a prerequisite for sustained antitumour immune responses. However, identifying predictive biomarkers that quantify T cell infiltration and the presence of proinflammatory

Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)

Natalizumab treatment in relapsing-remitting multiple sclerosis: can we safely personalise treatment intervals? In JNNP, Toorop and coworkers present the results of the NEXT-MS trial, a clinical trial on individualised extended interval dosing (EID) of natalizumab (NTZ) in people with relapsing-remitting

Intertwined depressive and cognitive trajectories and the risk of dementia and death in older adults: a competing risk analysis

Background Depressive symptoms and cognitive impairment often interact, rendering their associations controversial. To date, their joint trajectories and associations with dementia and death remain underexplored. Aims To explore the interactions between depressive symptoms and cognitive function, their developmental trajectories and

Data Errors

In the Original Investigation titled “Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials,” published in the April 25, 2023, issue of JAMA, there were errors in the categorization of statistical significance agreement for the

UpFront

FIT negative clinic as a safety net for low-risk colorectal cancer patients: impact on Endoscopy and Radiology utilisation – a retrospective cohort study Faecal immunochemical testing (FIT) is recommended by the National Institute for Health and Care Excellence to triage

Identifying regulatory loci across 38 lung cell types

Nature Genetics, Published online: 03 April 2024; doi:10.1038/s41588-024-01701-1 Using single-cell RNA-sequencing (scRNA-seq) of lung tissue, expression quantitative trait loci (eQTLs) were mapped across 38 cell types, revealing both shared and cell-type-specific effects. Highly cell-type-specific disease-interaction eQTLs were linked to cellular

Errors in Text and Figure 1

The Original Investigation titled “Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow’s Milk Allergy: A Randomized Clinical Trial,” published on February 26, 2024, was corrected to fix some typographical errors in the Methods and

WhatsApp WhatsApp'tan Bize Yazın